Jung and colleagues introduced a novel microfluidic platform designed to cultivate 3D lung cancer organoids and perform drug sensitivity assays within a single micro-physiological system (161)
Revenue and losses are based on collected insurance premiums, in addition to other revenue streams like investments, compared to how much was paid out for health care costs for members
Continuing Titration: For individuals who, in consultation with their provider, require continued titration and are tolerating the medication well, proceeding to a higher dose is a standard clinical approach
Specialty biologic drugs are expensive
Fatigue is reported by some GLP-1 users, but it's not listed as a primary side effect in major clinical trials and typically resolves within 24 weeks
Medicare coverage, patent expiries, and a rapidly expanding pipeline converge to bring obesity treatment to a far wider patient population than ever before